U
ELGX

UBS’s Endologix Inc ELGX Stock Holding History

UBS’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-60
Closed -$10K – 11049
2013
Q4 		$10K Buy
+60
New +$10.3K ﹤0.01% 9021

Other funds holding ELGX

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

UBS's ELGX Position: Q3 2014 in Review

UBS reduced its Endologix Inc (ELGX) stake by 62% in Q3 2014, selling an estimated $69.3K and leaving 300 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #7405.

UBS first reported a position in ELGX in Q2 2013 and has held it in 6 quarters since. The position peaked at $235K in Q3 2013. 120 funds tracked by Wall St. Rank hold ELGX as of Q3 2014.

  • UBS held 300 shares of Endologix Inc worth $32K as of Q3 2014.
  • UBS sold 497 Endologix Inc shares in Q3 2014, an estimated $69.3K.
  • Endologix Inc made up ﹤0.01% of UBS's portfolio in Q3 2014, its #7405 holding.
  • UBS first reported a position in Endologix Inc in Q2 2013 and has held it in 6 quarters since.
  • UBS's Endologix Inc position peaked at $235K in Q3 2013.
  • 120 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.